Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Ironwood pharmaceuticals, inc. symbols : ABBV save search
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.48%
H: 1.56%
C: 1.48%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: -5.63%
H: 7.34%
C: 2.81%
year pharmaceuticals ironwood financial
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
Published: 2023-11-09 (Crawled : 13:30) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -1.81%
H: 0.43%
C: -2.1%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: 2.93%
H: 4.37%
C: 0.21%
pharmaceuticals ironwood results
Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting
Published: 2023-10-23 (Crawled : 13:30) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.05%
H: 0.18%
C: -0.98%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: -0.87%
H: 0.87%
C: -1.64%
ironwood meeting
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
Published: 2023-08-08 (Crawled : 13:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: -3.96%
H: 0.0%
C: -5.41%
linzess sales year pharmaceuticals ironwood
Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
Published: 2022-11-03 (Crawled : 12:20) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.36%
H: 0.99%
C: 0.29%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: 2.92%
H: 1.42%
C: 0.71%
pharmaceuticals year financial
Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.29%
H: 0.34%
C: -2.23%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: -0.98%
H: 3.78%
C: 3.42%
linzess year
Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published: 2022-06-24 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -0.5%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 6.71%
H: 0.0%
C: -0.1%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 4.33%
H: 0.0%
C: -2.44%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: 0.0%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: 5.78%
H: 13.91%
C: 13.78%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: 0.27%
H: 2.08%
C: 1.99%
treatment market
Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 2.35%
H: 0.36%
C: -0.39%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: 0.74%
H: 2.13%
C: 0.33%
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2021
Published: 2022-02-17 (Crawled : 13:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.73%
H: 0.46%
C: 0.12%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: -3.64%
H: 1.32%
C: 0.09%
linzess sales als report results
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: -3.79%
H: 4.65%
C: 4.29%
Ironwood Pharmaceuticals Reports Third Quarter 2021 Results and Provides Corporate Development Update
Published: 2021-11-04 (Crawled : 12:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.89%
H: 0.13%
C: -0.43%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: -1.66%
H: 1.36%
C: 0.88%
results
Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Dosage Strength
Published: 2021-05-26 (Crawled : 21:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.03%
H: 0.18%
C: 0.15%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: 0.84%
H: 0.67%
C: -0.25%
ev
Ironwood Pharmaceuticals Reports First Quarter 2021 Results
Published: 2021-05-06 (Crawled : 17:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.67%
H: 1.03%
C: 0.94%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: -0.92%
H: 0.93%
C: -2.24%
results report
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.